Measles-containing-vaccine first-dose (MCV1) immunization coverage in Bahamas
Bahamas: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 91.0% in 2025. ▼ Falling
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Bahamas, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine first-dose (mcv1) immunization coverage in Bahamas stood at 91.0%.
That represents a change of up 5.8% on the previous year and down 3.2% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Bahamas peaked at 98.0% in 2009 and was at its lowest, 80.0%, in 2022.
That places Bahamas 91st out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently falling across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Bahamas, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 93.0% | — |
| 2001 | 94.0% | +1.1% |
| 2002 | 94.0% | +0.0% |
| 2003 | 90.0% | -4.3% |
| 2004 | 89.0% | -1.1% |
| 2005 | 85.0% | -4.5% |
| 2006 | 88.0% | +3.5% |
| 2007 | 96.0% | +9.1% |
| 2008 | 90.0% | -6.2% |
| 2009 | 98.0% | +8.9% |
| 2010 | 94.0% | -4.1% |
| 2011 | 90.0% | -4.3% |
| 2012 | 91.0% | +1.1% |
| 2013 | 92.0% | +1.1% |
| 2014 | 92.0% | +0.0% |
| 2015 | 94.0% | +2.2% |
| 2016 | 89.0% | -5.3% |
| 2017 | 90.0% | +1.1% |
| 2018 | 89.0% | -1.1% |
| 2019 | 83.0% | -6.7% |
| 2020 | 87.0% | +4.8% |
| 2021 | 82.0% | -5.7% |
| 2022 | 80.0% | -2.4% |
| 2023 | 86.0% | +7.5% |
| 2024 | 86.0% | +0.0% |
| 2025 | 91.0% | +5.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 91.7% | 85.0% | 98.0% | 10 |
| 2010s | 90.4% | 83.0% | 94.0% | 10 |
| 2020s | 85.3% | 80.0% | 91.0% | 6 |
Countries ranked near Bahamas
More health data for Bahamas
- Un projection of annual infant deaths, annual growth rate -11.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0809 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,358 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8 deaths (2100)
- Population ages 0-14, female, annual growth rate -1.6 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 0-14, female, per capita 0.0867 units per person (2025)
- Population ages 0-14, male, annual growth rate -1.61 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 0-14, male, per capita 0.0888 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Bahamas?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Bahamas was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Bahamas?
- The highest recorded value was 98.0% in 2009.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Bahamas?
- The lowest recorded value was 80.0% in 2022.
- How does Bahamas rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Bahamas ranks 91st out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Bahamas?
- Over the last ten years it is down 3.2%. The long-run trend across the full record is falling.
- Where does this Bahamas data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).